Racial Disproportionality in Covid Clinical Trials

This article reports on the lack of diversity in many clinical trials in COVID-19, and calls for more data on drug treatment in minority groups as data suggest they experience disproportionately higher rates of Covid-19 infection, hospitalisation, and death.

Source:

New England Journal of Medicine